DeShazer's approach to mammographies explores the rapidly increasing use of photographic technology, taking as its subject people of every race and nationality. These photographic images, which can be posted on the Internet every minute of every day, represent heterosexual, pregnant, lesbian, young, old, male, female, and transgendered individuals, among others. According to DeShazer, when the artist Matuschka published photos of her postmastectomy chest in The New York Times in 1993, she quickly propelled breast cancer narratives into mammographies and thus to postmillenial visual and global discussions about women's postmastectomy bodies. Catherine Lord, self-described cancer butch, created a photographic biography, The Summer of Her Baldness: A Cancer Improvisation (2004) , that is filled with images of rage, acceptance, resistance, and beauty as she orders the photos in a nonlinear way. DeShazer suggests that Lord's way of depicting herself destabilizes the categorization of cancer as weakness.
Photographing women as they are dying from breast cancer is not without controversy. When Annie Leibovitz published A Photographer 's Life (2006) , a book about lover Susan Sontag, critics were aghast at the way Leibovitz portrayed the final years of Sontag's struggle with breast cancer. Sontag, who worked so hard to reverse both negative metaphors of cancer and the dehumanization of those with (breast) cancer, is shown in familiar ways, argues Leibovitz, who photographed Sontag's fragility and physical weakness. But others, including Sontag's son, think otherwise. He contends that Leibovitz took advantage of her lover's fame by exposing Sontag in ways that she would not want to be remembered. The many photonarratives discussed in DeShazer's book are tasteful, startling, stunning, and even humorous as they mourn and celebrate postmastectomy embodiment.
DeShazer examines how genetic and medical advances have replaced the premillennial emphasis on early detection with the postmillennial philosophy of prevention first and detection second. She writes about the recent interest in the controversial BRCA1 and BRCA2 breast and ovarian "cancer genes" and looks at "previvor" narratives by Eisenstein, Janet Reibstein, Elizabeth Bryan, and Jessica Queller. Since Eisenstein's mother and two sisters died from breast and ovarian cancers, she was encouraged by her doctor to have a prophylactic oophorectomy; later, she had a mastectomy after being diagnosed with Stage 1 breast cancer. Despite the family history, Eisenstein chose not to be tested for the genetic mutations. The decision not to undergo genetic testing, DeShazer shows, should not be viewed as surprising or irrational: some women fear discrimination from insurance companies, while others believe that testing positive does not mean that they will get breast cancer. In fact, argues DeShazer, only forty percent of those who tested positive for the genetic mutations have actually developed cancer. Reibstein's and Bryan's narratives poignantly articulate worries about how the surgeries will impact their relationships with their husbands and children, yet both of them elect to have the operations. Queller, who is single, worries that it will be harder to find an understanding partner now that she has tested positive for the genetic mutations. She, too, elects for the prophylactic mastectomy. By writing about women with different lifestyles, with different reasons for opting or not opting to be tested for the gene mutations, the book creates a space where discussions and counter-discussions about genetic mutations and prophylactic surgery can occur.
Perhaps DeShazer's greatest contribution to postmillennial breast cancer studies is her call for the continuing celebration of breast cancer survivorship even as she appeals for public and political texts to pay greater attention to those who are dying or have already died. Anti-pink, or "pink washing," is a term that first appeared on the Internet in 2011 and refers to campaigns that question the oversaturation of pink products. More and more companies are choosing to produce pink products, knowing that the consumer is more likely to choose that product over a competitor's because of the association with a breast cancer charity. DeShazer and others, however, believe that consumers of pink products all too often forget about the ugliness of breast cancer, which is, after all, a deadly disease. Though some may disagree with DeShazer on this matter, she once again creates spaces for disseminating knowledge and interrogating norms.
Illness narratives about breast cancer often call to mind Audre Lordearguably the first narrator of a breast cancer journal. Lorde expressed deep loneliness, almost as if she were writing in the dark, with no person like her to give her comfort. Readers may ask themselves, "What would Audre Lorde think about this new postmillenial breast cancer discourse?" Mammographies would make Lorde, that one-breasted Amazonian goddess, very proud. DeShazer is a courageous, tenacious writer who dares to map the progress of breast cancer studies for the first time, in all of its flaws and ugliness, and in all of its beauty and eloquence.
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Both original and provocative, Paula Backscheider's new book is also deeply learned and comprehensive in its scholarship and in its boldly "revisionary" (her word) ambitions (p. 40). Elizabeth Singer Rowe (1674-1737) was a celebrated poet and epistolary fiction writer, whose works were
